drug resistance
The company plans to release Ampore-TB for research use only later this year, followed by regulatory submissions in the US and Europe.
WHO Publishes New Guidance Recommending Targeted NGS for Drug-Resistant TB Diagnosis
The WHO specifically highlighted targeted sequencing assays from Genoscreen, Oxford Nanopore Diagnostics, and Hangzhou ShengTing Medical Technology.
Illumina, GenoScreen Partner to Comarket Genomic Testing for Multidrug-Resistant TB
The firms will comarket Illumina next-generation sequencing reagents with GenoScreen's Deeplex Myc-TB NGS-based test for antibiotic resistance in TB.
The multi-year project led by FIND is currently evaluating three end-to-end solutions through clinical studies.
WHO Updates Recommendations to Improve Access to Rapid MDx Tests for TB, Drug-Resistant TB
The WHO recommended moderate-complexity, automated nucleic acid amplification test for the initial detection of TB and resistance to rifampicin and isoniazid.